Citic-controlled Harbin Pharmaceutical To Invest $300M In US Wellness Company GNC, Becoming Biggest Shareholder

Login to View

Citic Capital-controlled Harbin Pharmaceutical Group Holding, known as Hayao, has agreed to invest US$300 million in U.S.-based health and wellness retailer GNC Holdings, becoming the single largest shareholder in NYSE-traded GNC.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in